Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Davis

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|May 22, 2010
TNF receptor 2 pathway: drug target for autoimmune diseasesDenise Faustman, Miriam Davis
The International Journal of Biochemistry & Cell Biology|July 6, 2010
Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disordersDenise L Faustman, Miriam Davis
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2009
The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapiesDenise L Faustman, Miriam Davis
Frontiers in Immunology|January 7, 2014
TNF Receptor 2 and Disease: Autoimmunity and Regenerative MedicineDenise L Faustman, Miriam Davis
JAMA Ophthalmology|February 17, 2022
Moving Beyond COVID-19-How the Pandemic Is Associated With Transformations in Research and Careers of the Next Generation of Vision ScientistsJames Jorkasky, Miriam Davis, Paul P Lee
Trends in Molecular Medicine|June 14, 2005
Regenerative medicine: a radical reappraisal of the spleenShohta Kodama, Miriam Davis, Denise L Faustman
JAMA Ophthalmology|July 1, 2021
Potential Impact of COVID-19 Disruptions on the Next Generation of Vision ScientistsJames Jorkasky, Miriam Davis, Paul P Lee
Science of Aging Knowledge Environment : SAGE KE|January 22, 2005
Diabetes and stem cell researchers turn to the lowly spleenShohta Kodama, Miriam Davis, Denise L Faustman
Advances in Physiology Education|November 17, 2006
A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune responseElizabeth Dale, Miriam Davis, Denise L Faustman
International Journal of Molecular Sciences|August 28, 2025
TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related DiseasesDenise L Faustman, Miriam Davis, Willem M Kuhtreiber
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|May 22, 2010
TNF receptor 2 pathway: drug target for autoimmune diseasesDenise Faustman, Miriam Davis
The International Journal of Biochemistry & Cell Biology|July 6, 2010
Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disordersDenise L Faustman, Miriam Davis
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2009
The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapiesDenise L Faustman, Miriam Davis
Frontiers in Immunology|January 7, 2014
TNF Receptor 2 and Disease: Autoimmunity and Regenerative MedicineDenise L Faustman, Miriam Davis
JAMA Ophthalmology|February 17, 2022
Moving Beyond COVID-19-How the Pandemic Is Associated With Transformations in Research and Careers of the Next Generation of Vision ScientistsJames Jorkasky, Miriam Davis, Paul P Lee
Trends in Molecular Medicine|June 14, 2005
Regenerative medicine: a radical reappraisal of the spleenShohta Kodama, Miriam Davis, Denise L Faustman
JAMA Ophthalmology|July 1, 2021
Potential Impact of COVID-19 Disruptions on the Next Generation of Vision ScientistsJames Jorkasky, Miriam Davis, Paul P Lee
Science of Aging Knowledge Environment : SAGE KE|January 22, 2005
Diabetes and stem cell researchers turn to the lowly spleenShohta Kodama, Miriam Davis, Denise L Faustman
Advances in Physiology Education|November 17, 2006
A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune responseElizabeth Dale, Miriam Davis, Denise L Faustman
International Journal of Molecular Sciences|August 28, 2025
TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related DiseasesDenise L Faustman, Miriam Davis, Willem M Kuhtreiber
Pageof 3